BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 6153283)

  • 1. Increased sensitivity to intracerebroventricular infusion of serotonin and deaminated indoles after lesioning rat with dihydroxytryptamine.
    Warbritton JD; Stewart RM; Baldessarini RJ
    Brain Res; 1980 Feb; 183(2):355-66. PubMed ID: 6153283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 5,7-dihydroxytryptamine on the development of tolerance to ethanol.
    Lê AD; Khanna JM; Kalant H; LeBlanc AE
    Psychopharmacology (Berl); 1980 Feb; 67(2):143-6. PubMed ID: 6768090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased behavioural response to 5-methoxy-N,N-dimethyltryptamine but not to RU-24969 after intraventricular 5,7-dihydroxytryptamine administration.
    Nisbet AP; Marsden CA
    Eur J Pharmacol; 1984 Sep; 104(1-2):177-80. PubMed ID: 6499914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor mechanisms in increased sensitivity to serotonin agonists after dihydroxytryptamine shown by electronic monitoring of muscle twitches in the rat.
    Stewart RM; Campbell A; Sperk G; Baldessarini RJ
    Psychopharmacology (Berl); 1979 Feb; 60(3):281-9. PubMed ID: 108706
    [No Abstract]   [Full Text] [Related]  

  • 5. Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity.
    Black RS; Robinson RG
    Pharmacol Biochem Behav; 1985 Feb; 22(2):327-31. PubMed ID: 3983223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model of central chemical 'serotoninectomy' in mice.
    Herman ZS; Bonczek A
    Pharmacology; 1978; 17(1):8-14. PubMed ID: 684075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brainstem serotonergic hyperinnervation modifies behavioral supersensitivity to 5-hydroxytryptophan in the rat.
    Pranzatelli MR; Huang YY; Dollison AM; Stanley M
    Brain Res Dev Brain Res; 1989 Nov; 50(1):89-99. PubMed ID: 2582610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin-lesion myoclonic syndromes. II. Analysis of individual syndrome elements, locomotor activity and behavioral correlations.
    Pranzatelli MR; Snodgrass SR
    Brain Res; 1986 Jan; 364(1):67-76. PubMed ID: 3484993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
    Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The guinea pig myoclonic model: behavioral supersensitivity to 5-hydroxytryptophan induced by intracisternal 5,7-dihydroxytryptamine.
    Pranzatelli MR; Snodgrass SR
    Eur J Pharmacol; 1987 Nov; 143(2):237-42. PubMed ID: 3500866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraventricular 5,7-dihydroxytryptamine increases thyrotropin-releasing hormone content in regions of rat brain.
    Manaker S; Engber TM; Knight PB; Winokur A
    J Neurochem; 1985 Oct; 45(4):1315-8. PubMed ID: 3928818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar motor effects of 5-HT and TRH in rats following chronic spinal transection and 5.7-dihydroxytryptamine injection.
    Barbeau H; Bédard P
    Neuropharmacology; 1981 May; 20(5):477-81. PubMed ID: 6165921
    [No Abstract]   [Full Text] [Related]  

  • 13. The behavioral effects of depletions of brain serotonin induced by 5,7-dihydroxytryptamine vary with time after administration.
    Gately PF; Segal DS; Geyer MA
    Behav Neural Biol; 1986 Jan; 45(1):31-42. PubMed ID: 3954713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Mueller RA
    J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of neonatal administration of 5,7-dihydroxytryptamine on locomotor activity.
    Lucot JB; Seiden LS
    Psychopharmacology (Berl); 1982; 77(2):114-6. PubMed ID: 6812128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebroventricular administration of 5,7-dihydroxytryptamine to mice increases both head-twitch response and the number of cortical 5-HT2 receptors.
    Heal DJ; Philpot J; Molyneux SG; Metz A
    Neuropharmacology; 1985 Dec; 24(12):1201-5. PubMed ID: 4094656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of intraventricular injection of 5,7-dihydroxytryptamine on monoamines and sleep in the kitten (author's transl)].
    Adrien J; Bourgoin S; Laguzzi R; Hamon M
    J Physiol (Paris); 1981; 77(2-3):425-30. PubMed ID: 7288656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced selective 5-HT depletions in the DHT rat model: denervation supersensitivity and recovery of function.
    Pranzatelli MR; Snodgrass SR
    Psychopharmacology (Berl); 1986; 89(4):449-55. PubMed ID: 3092275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal serotonin re-uptake and nocturnal locomotor activity after microinjections of 5,7-DHT in the fornix-fimbria.
    Williams JH; Azmitia EC
    Brain Res; 1981 Feb; 207(1):95-107. PubMed ID: 7470907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of 5,7-dihydroxytryptamine-induced supersensitivity to 5-hydroxytryptophan in mice by treatment with cycloheximide.
    Sperk G; Stewart RM; Campbell A; Baldessarini RJ
    Brain Res; 1978 Dec; 159(1):183-94. PubMed ID: 310331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.